Letter to cancer center directors: Progress in quantitative imaging as a means to predict and/or measure tumor response in cancer therapy trials.
作者信息
Mountz James M, Yankeelov Thomas E, Rubin Daniel L, Buatti John M, Erikson Bradley J, Fennessy Fiona M, Gillies Robert J, Huang Wie, Jacobs Michael A, Kinahan Paul E, Laymon Charles M, Linden Hannah M, Mankoff David A, Schwartz Lawrence H, Shim Hyunsuk, Wahl Richard L
机构信息
University of Pittsburgh, Pittsburgh, PA
Vanderbilt University, Nashville, TN.
出版信息
J Clin Oncol. 2014 Jul 1;32(19):2115-6. doi: 10.1200/JCO.2014.55.8866. Epub 2014 May 27.
Abstract
摘要
相似文献
1
Letter to cancer center directors: Progress in quantitative imaging as a means to predict and/or measure tumor response in cancer therapy trials.致癌症中心主任的信：定量成像在癌症治疗试验中作为预测和/或测量肿瘤反应手段的进展
J Clin Oncol. 2014 Jul 1;32(19):2115-6. doi: 10.1200/JCO.2014.55.8866. Epub 2014 May 27.
2
American Society of Clinical Oncology Developing First Clinical Trial.美国临床肿瘤学会正在开展首个临床试验。
J Natl Cancer Inst. 2015 Nov 4;107(11):djv356. doi: 10.1093/jnci/djv356. Print 2015 Nov.
3
National Cancer Institute partnerships with Academia and Industry in Cancer Diagnosis and Treatment: report of the workshop.美国国立癌症研究所与学术界和产业界在癌症诊断与治疗方面的合作：研讨会报告
Acad Radiol. 1998 Feb;5(2):133-40. doi: 10.1016/s1076-6332(98)80135-9.
4
National Cancer Institute's Precision Medicine Initiatives for the new National Clinical Trials Network.美国国立癌症研究所针对新的国家临床试验网络的精准医学计划。
Am Soc Clin Oncol Educ Book. 2014:71-6. doi: 10.14694/EdBook_AM.2014.34.71.
5
The clinical evaluation of novel imaging methods for cancer management.新型癌症治疗影像方法的临床评估。
Nat Rev Clin Oncol. 2012 Dec;9(12):738-44. doi: 10.1038/nrclinonc.2012.186. Epub 2012 Nov 13.
6
Imaging and Data Acquisition in Clinical Trials for Radiation Therapy.放射治疗临床试验中的成像与数据采集
Int J Radiat Oncol Biol Phys. 2016 Feb 1;94(2):404-11. doi: 10.1016/j.ijrobp.2015.10.028. Epub 2015 Oct 24.
7
Cancer: a roadmap for the land of small tumors.癌症：小肿瘤领域的路线图。
Nat Rev Endocrinol. 2011 Jun;7(6):319-21. doi: 10.1038/nrendo.2011.73. Epub 2011 Apr 26.
8
How Imaging Biomarkers Can Inform Clinical Trials and Clinical Practice in the Era of Targeted Cancer Therapy.在靶向癌症治疗时代，影像生物标志物如何为临床试验和临床实践提供信息。
JAMA Oncol. 2015 Jul;1(4):421-2. doi: 10.1001/jamaoncol.2015.0667.
9
Learning from exceptional drug responders.向药物超响应者学习。
Nat Rev Drug Discov. 2014 Jun;13(6):401-2. doi: 10.1038/nrd4338.
10
Institutional profile: Developing and evaluating new drugs for cancer treatment: perspectives from the US National Cancer Institute.机构简介：开发和评估用于癌症治疗的新药：来自美国国立癌症研究所的观点
Future Med Chem. 2010 Apr;2(4):555-9. doi: 10.4155/fmc.10.11.
引用本文的文献
1
Co-Clinical Imaging Resource Program (CIRP): Bridging the Translational Divide to Advance Precision Medicine.联合临床影像资源计划（CIRP）：弥合转化鸿沟，推进精准医学。
Tomography. 2020 Sep;6(3):273-287. doi: 10.18383/j.tom.2020.00023.
2
Clinical Trial Design and Development Work Group Within the Quantitative Imaging Network.临床实验设计与发展工作组，隶属于定量影像网络。
Tomography. 2020 Jun;6(2):60-64. doi: 10.18383/j.tom.2019.00022.
3
Improving Cancer Diagnosis and Care: Patient Access to Oncologic Imaging Expertise.改善癌症诊断与护理：患者获得肿瘤影像专业知识的途径。
J Clin Oncol. 2019 Jul 10;37(20):1690-1694. doi: 10.1200/JCO.18.01970. Epub 2019 May 3.
4
QIN Benchmarks for Clinical Translation of Quantitative Imaging Tools.定量成像工具临床翻译的秦氏基准。
Tomography. 2019 Mar;5(1):1-6. doi: 10.18383/j.tom.2018.00045.
5
Dynamic contrast-enhanced magnetic resonance imaging and diffusion-weighted magnetic resonance imaging for predicting the response of locally advanced breast cancer to neoadjuvant therapy: a meta-analysis.动态对比增强磁共振成像和扩散加权磁共振成像预测局部晚期乳腺癌对新辅助治疗反应的Meta分析
J Med Imaging (Bellingham). 2018 Jan;5(1):011011. doi: 10.1117/1.JMI.5.1.011011. Epub 2017 Nov 24.
6
Imaging Considerations and Interprofessional Opportunities in the Care of Breast Cancer Patients in the Neoadjuvant Setting.新辅助治疗背景下乳腺癌患者护理中的影像学考量与跨专业合作机会
Semin Oncol Nurs. 2017 Nov;33(4):425-439. doi: 10.1016/j.soncn.2017.08.008. Epub 2017 Sep 15.
7
Expected Impacts of Connected Multimodal Imaging in Precision Oncology.精准肿瘤学中连通多模态成像的预期影响。
Front Pharmacol. 2016 Nov 29;7:451. doi: 10.3389/fphar.2016.00451. eCollection 2016.
8
The Importance of Biopsy in the Era of Molecular Medicine.活检在分子医学时代的重要性。
Cancer J. 2016 Nov/Dec;22(6):418-422. doi: 10.1097/PPO.0000000000000228.
9
Quantitative Imaging in Cancer Clinical Trials.癌症临床试验中的定量成像
Clin Cancer Res. 2016 Jan 15;22(2):284-90. doi: 10.1158/1078-0432.CCR-14-3336.
10
Correlation between (18)F-FDG uptake on PET/CT and prognostic factors in triple-negative breast cancer.PET/CT上(18)F-FDG摄取与三阴性乳腺癌预后因素的相关性
Eur Radiol. 2015 Nov;25(11):3314-21. doi: 10.1007/s00330-015-3734-z. Epub 2015 Apr 23.
本文引用的文献
1
Measuring response in a post-RECIST world: from black and white to shades of grey.在RECIST标准之后的时代衡量反应：从黑白到灰度渐变
Nat Rev Cancer. 2006 May;6(5):409-14. doi: 10.1038/nrc1883.
Zotero 插件